MXPA02003742A - Treatment of dermal tumors, warts, and viral infections using heat killed p. acnes. - Google Patents

Treatment of dermal tumors, warts, and viral infections using heat killed p. acnes.

Info

Publication number
MXPA02003742A
MXPA02003742A MXPA02003742A MXPA02003742A MXPA02003742A MX PA02003742 A MXPA02003742 A MX PA02003742A MX PA02003742 A MXPA02003742 A MX PA02003742A MX PA02003742 A MXPA02003742 A MX PA02003742A MX PA02003742 A MXPA02003742 A MX PA02003742A
Authority
MX
Mexico
Prior art keywords
acnes
warts
treatment
viral infections
heat killed
Prior art date
Application number
MXPA02003742A
Other languages
Spanish (es)
Inventor
Bobby G Edwards
Original Assignee
Kampen Group Inc Van
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kampen Group Inc Van filed Critical Kampen Group Inc Van
Publication of MXPA02003742A publication Critical patent/MXPA02003742A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
MXPA02003742A 1999-10-15 2000-10-13 Treatment of dermal tumors, warts, and viral infections using heat killed p. acnes. MXPA02003742A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15956799P 1999-10-15 1999-10-15
PCT/US2000/028361 WO2001054727A1 (en) 1999-10-15 2000-10-13 Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes

Publications (1)

Publication Number Publication Date
MXPA02003742A true MXPA02003742A (en) 2003-10-14

Family

ID=22573102

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02003742A MXPA02003742A (en) 1999-10-15 2000-10-13 Treatment of dermal tumors, warts, and viral infections using heat killed p. acnes.

Country Status (5)

Country Link
EP (1) EP1220688A1 (en)
AU (1) AU1201801A (en)
CA (1) CA2383626A1 (en)
MX (1) MXPA02003742A (en)
WO (1) WO2001054727A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
JP2002534468A (en) 1999-01-13 2002-10-15 バイエル コーポレイション ω-Carboxyaryl-substituted diphenylureas as p38 kinase inhibitors
EP2324825A1 (en) 2002-02-11 2011-05-25 Bayer Healthcare LLC Aryl ureas with angiogenesis inhibiting activity
ATE366108T1 (en) 2003-05-20 2007-07-15 Bayer Pharmaceuticals Corp DIARYL UREAS FOR PDGFR-MEDIATED DISEASES
NZ580384A (en) 2003-07-23 2011-03-31 Bayer Pharmaceuticals Corp 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
US7662781B2 (en) 2005-01-31 2010-02-16 Eci, Inc. Immunopotentiating agent
EP2455092A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
CN117511758A (en) * 2022-08-04 2024-02-06 复旦大学附属华山医院 Propionibacterium acnes, uses, compositions and medicaments thereof
CN115317520B (en) * 2022-09-06 2024-04-05 浙江大学 Zinc-aluminum hydrotalcite-like compound-propionibacterium acnes bacterial hybrid material and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
JPS59161320A (en) * 1983-03-04 1984-09-12 Maruyama Chisato Lipopolysaccharide and its preparation

Also Published As

Publication number Publication date
AU1201801A (en) 2001-08-07
WO2001054727A1 (en) 2001-08-02
EP1220688A1 (en) 2002-07-10
CA2383626A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
AU2002341361A1 (en) Device, system, and method for cryosurgical treatment of cardiac arrhythmia
DK1185319T3 (en) Cardiac aids, systems and procedures
AU2001231029A1 (en) Heat exchange catheter with improved insulated region
AU2001294604A1 (en) Improved radiation therapy treatment method
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
AU2989900A (en) Microwave systems for medical hyperthermia, thermotherapy and diagnosis
HK1061679A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use.
MX264033B (en) Enzyme treatment for infection.
ZA200201834B (en) Vaccine against HBV and HPV.
AU2001265253A1 (en) Treatment of hiv using hyperthermia
MXPA02003742A (en) Treatment of dermal tumors, warts, and viral infections using heat killed p. acnes.
WO2001055111A8 (en) Biaryl compounds, their preparation and their use in therapy
AU2627800A (en) Treatment of lymphomas, leukemias, and leiomyomas
HK1033671A1 (en) Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses.
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
HK1050011A1 (en) Treatment of viral infections using levovirintm
AU7679300A (en) Electromagnetic method of treatment of lesions associated with inadequate blood perfusion, partial denervation, tissue loss, pain, edema, inflammation and infection
MXPA02005978A (en) Hair treatment composition comprising cationic surfactants.
PT888114E (en) USING (+) - ALPHA- (2,3-DIMETOXYPHENYL) -1- [2- (4-FLUOROPHENYL) ETHYL] -4-PIPERIDINOMETHANOL IN THE TREATMENT OF DEPRESSIVE DISEASES AND BIPOLAR DISEASES
HK1041661A1 (en) Electromedical treatment applicator.
AU4259299A (en) New sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections
AP2002002432A0 (en) Treatment of viral infections
ZA200203166B (en) Treatment of cancer.
AU4227400A (en) Therapeutical steam and heat treatment cabinet